Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health.

Drug safety·2024
Same author

Clinical use of gastric antisecretory drugs in pediatric patients with gastroesophageal reflux disease: a narrative review.

Translational pediatrics·2023
Same author

Clinical Use of Gastric Antisecretory Drugs in Hospitalized Pediatric Patients.

Journal of clinical medicine·2023
Same author

Use of Azithromycin in Pregnancy: More Doubts than Certainties.

Clinical drug investigation·2022
Same author

Paracetamol overdose in the newborn and infant: a life-threatening event.

European journal of clinical pharmacology·2021
Same author

Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough?

Fundamental & clinical pharmacology·2020

Related Experiment Video

Updated: Jul 5, 2026

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Phytotherapic compounds: the consumer-pharmacist relationship.

Marco Bacchini1, Laura Cuzzolin, Thomas Camerlengo

  • 1Pharmacists' Association, Verona, Italy.

Drug Safety
|April 22, 2008
PubMed
Summary

Consumer use of herbal products is rising in Italy, with many perceiving them as safe and effective. Pharmacists provide better information on herbal uses than on potential drug interactions or adverse effects.

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Field Identification of Matricaria chamomilla using a Portable qPCR System
12:08

Field Identification of Matricaria chamomilla using a Portable qPCR System

Published on: October 10, 2020

Related Experiment Videos

Last Updated: Jul 5, 2026

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Field Identification of Matricaria chamomilla using a Portable qPCR System
12:08

Field Identification of Matricaria chamomilla using a Portable qPCR System

Published on: October 10, 2020

Area of Science:

  • Pharmacology and Phytotherapy
  • Consumer Health Behaviors

Background:

  • Pharmacists are crucial for educating consumers about natural products and their risks, especially concerning interactions with conventional medications.
  • The increasing popularity of phytotherapy necessitates an evaluation of the quality of pharmacist counseling in this area.

Purpose of the Study:

  • To investigate the quality of self-care counseling provided by pharmacists regarding phytotherapy.
  • To assess consumer perceptions of herbal products and their interactions with conventional drugs.

Main Methods:

  • A survey was conducted in 23 Italian pharmacies between November 2006 and April 2007.
  • Trained pharmacists interviewed 1420 consumers purchasing herbal products using a pre-structured questionnaire.
  • The questionnaire gathered data on demographics, reasons for use, product knowledge, healthcare provider communication, satisfaction, and concurrent drug use.

Main Results:

  • Herbal product use is increasing in Italy, with 12% of consumers purchasing for the first time.
  • Consumers perceive phytotherapy as effective for health promotion, wellness, and disease management, and safer than conventional drugs.
  • Pharmacists demonstrated higher accuracy in answering questions about herbal medicine uses compared to drug interactions, adverse effects, and precautions.

Conclusions:

  • The study highlights a growing trend in herbal product consumption and positive consumer perceptions of phytotherapy.
  • Pharmacist counseling quality varies, with a notable gap in knowledge regarding potential risks and interactions of herbal medicines.
  • Further training for pharmacists on the comprehensive safety aspects of phytotherapy is recommended to ensure optimal patient care.